Lykos Therapeutics Clinical Trials
Sponsors / Lykos Therapeutics
According to ClinicalTrials.gov, Lykos Therapeutics has served as lead sponsor on 25 registered trials. 0 trials are actively recruiting participants, 0 remain active without open enrollment, and 20 have concluded. 3 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include slow or insufficient recruitment, safety concerns. The cumulative planned enrollment figure across all listed trials is 923 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.
25
Total Trials
0
Recruiting
0
Other Active
20
Completed
3
Terminated / Withdrawn
923
Total Enrollment
Termination reasons: Recruitment67% · Safety33%
Recent Terminations
- PTSD"The study was terminated early by the sponsor due to administrative, non-safety related reasons."
- Posttraumatic Stress Disorder"This pilot study was terminated early by sponsor due to insufficient rate of accrual."
- Posttraumatic Stress Disorder"This study was terminated after enrolling five subjects due to staff turnover and its effects on quality of data collection."